Relay Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Relay Therapeutics, a clinical-stage precision medicine company (Nasdaq: RLAY), will participate in two upcoming investor conferences. The management will join the TD Cowen 5th Annual Oncology Innovation Summit virtually on May 28, 2024, at 9:30 a.m. ET and the Goldman Sachs 45th Annual Global Healthcare Conference on June 12, 2024, at 8:40 a.m. ET. Both events will be webcast live and accessible through Relay Therapeutics' website, with replays available for 30 days.

Positive

• Participation in two significant investor conferences showcases Relay Therapeutics' commitment to engaging with the investment community.
• The events will be webcast live, increasing accessibility for a broader audience, which can enhance investor relations.
• The inclusion of archived replays for 30 days allows for extended visibility and investor engagement.

Negative

• The press release lacks specific details about new clinical data or financial updates, which might be important for investors seeking substantive information.
• No new partnerships, collaborations, or business developments were announced, which could have added more value for current and potential investors.

CAMBRIDGE, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, today announced that management will participate in two upcoming fireside chats:

• TD Cowen 5th Annual Oncology Innovation Summit, taking place virtually on Tuesday, May 28, 2024 at 9:30 a.m. ET
• Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, 2024 at 8:40 a.m. ET

The fireside chats will be webcast live and may be accessed through Relay Therapeutics’ website under Events in the News & Events section through the following link: https://ir.relaytx.com/news-events/events-presentations. An archived replay of the webcast will be available for up to 30 days following the event.

About Relay Therapeutics

Relay Therapeutics is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. As the first of a new breed of biotech created at the intersection of complementary techniques and technologies, Relay Therapeutics aims to push the boundaries of what’s possible in drug discovery. Its Dynamo™ platform integrates an array of leading-edge computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. Relay Therapeutics’ initial focus is on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. For more information, please visit www.relaytx.com or follow us on Twitter.

Contact:
Megan Goulart
617-545-5526
mgoulart@relaytx.com

Media:
Dan Budwick
1AB
973-271-6085
dan@1abmedia.com

FAQ

When will Relay Therapeutics participate in the TD Cowen 5th Annual Oncology Innovation Summit?

Relay Therapeutics will participate in the TD Cowen 5th Annual Oncology Innovation Summit on May 28, 2024, at 9:30 a.m. ET.

When is Relay Therapeutics' presentation at the Goldman Sachs 45th Annual Global Healthcare Conference?

Relay Therapeutics will present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 12, 2024, at 8:40 a.m. ET.

How can I watch Relay Therapeutics' fireside chats at the upcoming investor conferences?

The fireside chats will be webcast live and can be accessed through Relay Therapeutics' website under the Events section.

Will replays of Relay Therapeutics' investor conference presentations be available?

Yes, archived replays of the webcast will be available for up to 30 days following the events.